ShamikChakrabortyMD

Clinical Trials

• Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab) Start of enrollment: 2009 Jul 01

  Completed

  Phase 1

• Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA Start of enrollment: 2009 Dec 01

  Completed

  Phase 1

• Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA Start of enrollment: 2010 Oct 01

  Recruiting

  Phase 1, Phase 2

• Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM Start of enrollment: 2013 Feb 01

  Completed

  Phase 1, Phase 2

• Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2015 May 01

  Terminated

  Phase 1

• Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA Start of enrollment: 2016 May 01

  Recruiting

  Phase 2

• Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma Start of enrollment: 2016 Jun 01

  Recruiting

  Phase 1, Phase 2

• Join now to see all